Riot Platforms, Inc. — Director's Dealing 2010

Mar 26, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2010-03-24

Reporting Person: Lundy Steve (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-24	Stock Option (Right to Buy)	$2.28	A	400000	Acquired	2020-03-24	Common Stock (400000)	Direct

Footnotes

F1: The non-qualified stock options to purchase 400,000 shares of common stock shall become exercisable as to 33.3% of the shares on each of March 24, 2011 and
March 24, 2012, and as to the remaining 33.4% of the shares on March 24, 2013. Acceleration of the vesting of 100,000 of the stock options may occur if certain
corporate events are achieved.